EUVIMEDOpdag EUVIMED
Crossref

Genotyping of the MTHFR Gene Polymorphism, C677T in Patients with Leukemia by Melting Curve Analysis

Ugur Deligezer, Ebru Akisik, Nejat Dalay

Molecular Diagnosis · 2003

DOI: 10.1007/bf03260036 ↗

At a glance

Journal article in Molecular Diagnosis, 2003. Written by Ugur Deligezer and 2 co-authors. Institution: Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey. Cited 19 times so far (Crossref); 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) plays a critical role in folate metabolism and displays common genetic polymorphisms affecting the enzyme activity. The MTHFR genetic polymorphisms have been associated with a decrease in the risk of developing the lymphoid but not myeloid form of pediatric and adult leukemias. AIM: In this study we describe the genotyping of the MTHFR C677T polymorphism by melting curve analysis with the LightCycler in a case-controlled study of patients with acute lymphocytic leukemia (ALL), myelogenous leukemia (AML), and chronic myelogenous leukemia (CML), and assess the effect of this common polymorphism on the leukemia risk in adult patients in Turkey. METHODS: DNA from peripheral blood lymphocytes was used for genotyping in the LightCycler PCR by melting curve analysis. The risk of leukemia associated with the MTHFR polymorphism was evaluated by comparing the genotype frequencies between the control and patient groups. RESULTS: The frequency of the homozygote variant genotype (677TT) was lower than that in healthy individuals in all three leukemia groups. The 677TT genotype did not appear to have a protective effect in patients with ALL (Odds ratio [OR] = 0.78 with a 95% confidence interval [CI] = 0.24-2.59), compared with healthy controls. The difference was higher (4.3-fold) in patients with AML, but still non-significant (OR = 0.23 with a 95% CI = 0.03-1.83). In patients with CML, the frequencies of both heterozygous (677CT) and homozygote variant genotypes were lower (OR = 0.72 and 0.66, respectively). CONCLUSIONS: Our results suggest that the MTHFR C677T polymorphism displays a similar distribution pattern in lymphoid and myeloid leukemias and that the frequency of the homozygote variant genotype (677TT) is lower in all leukemia types.

Subjects

MeSH terms (MEDLINE)

AdolescentAdultAgedBase SequenceDNA PrimersDNA, NeoplasmFemaleGenetic VariationGenotypeHumansLeukemiaMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedNucleic Acid DenaturationPolymerase Chain ReactionPolymorphism, Single NucleotideRisk Factors

Substances

DNA PrimersDNA, NeoplasmMethylenetetrahydrofolate Reductase (NADPH2)

Authors and institutions

  • Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey.

Cite

APA

Deligezer, U., Akisik, E., & Dalay, N. (2003). Genotyping of the MTHFR Gene Polymorphism, C677T in Patients with Leukemia by Melting Curve Analysis. Molecular Diagnosis. https://doi.org/10.1007/bf03260036

Vancouver

Deligezer U, Akisik E, Dalay N. Genotyping of the MTHFR Gene Polymorphism, C677T in Patients with Leukemia by Melting Curve Analysis. Molecular Diagnosis. 2003. doi:10.1007/bf03260036

BibTeX
@article{Deligezer2003,
  author = {Deligezer, Ugur and Akisik, Ebru and Dalay, Nejat},
  title = {Genotyping of the MTHFR Gene Polymorphism, C677T in Patients with Leukemia by Melting Curve Analysis},
  journal = {Molecular Diagnosis},
  year = {2003},
  doi = {10.1007/bf03260036}
}
Start for free →